VOGX
Vogenx, Inc.CIK 0001903784 · SIC 2834 · Pharmaceutical Preparations
No XBRL size data yet — common for recent IPOs and new registrants (SEC companyfacts lag), foreign filers reporting in non-USD, or non-standard filers.
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (NTSK 10-Q) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade VOGX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Vogenx prices $81.2M IPO at $13/share; clinical-stage biotech with material weaknesses and going-concern warning
7 material changes detected. Sign up free to read the summary.
Vogenx removes funding conditions from trial timelines in latest S-1/A
4 material changes detected. Sign up free to read the summary.
Summary not yet generated.
Summary not yet generated.